speb/financial-data huggingface dataset:
Financial ratios for CTAC.AS — annual report dated 2022-12-31
Total revenue: 125182978.72340426
Gross profit: 33722340.42553192
Operating income: 7064893.617021277
Net income: 5364893.617021277
Capital expenditures: 869148.9361702128
Operating cash flow: 6080851.063829788
Depreciation & amortization: 5736170.212765958
Net tangible assets: 1135106.3829787234
Owner earnings: 10231914.893617023
Return on net tangible assets (%): 901.4058106841613
Capex to operating income (%): 12.302364101791898
Buffett classification: The Great
Stock price: 3.138297872340426
P/E ratio: 8.276743575252826
Shares outstanding: 14149023
Book value: 32906382.978723414
P/B ratio: 1.3493992580499155
Market cap (USD): 44403848.77659575
Debt to equity: 0.3931850510797878
Current ratio: 0.984002621544328
Quick ratio: 0.978044566253575
Effective tax rate (%): 21.190811064228786
Interest coverage ratio: 13.981052631578946
COGS to revenue (%): 73.0615609490788
SG&A to revenue (%): 1.2118430892650758
Free cash flow (dilution-adjusted): 4723404.255319149
Buyback yield (%): 0
Retained earnings: 5029787.234042553
Inventory turnover: 429.865
Receivables turnover: 7.978844589096827
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.808140918828848
FCF margin (%): 3.7732000815827047
Rule of 40 score: 3.7732000815827047
Financial ratios for CTAC.AS — annual report dated 2023-12-31
Total revenue: 141366666.66666666
Gross profit: 34144444.44444444
Operating income: 5506666.666666667
Net income: 1260000
Capital expenditures: 1398888.8888888888
Operating cash flow: 11877777.777777778
Depreciation & amortization: 5795555.555555555
Net tangible assets: 1843333.3333333333
Owner earnings: 5656666.666666666
Return on net tangible assets (%): 306.871609403255
Capex to operating income (%): 25.403551251008878
Buffett classification: The Good
Stock price: 3.3222222222222224
P/E ratio: 37.30650685185186
Shares outstanding: 14149023
Book value: 31678888.888888888
P/B ratio: 1.483833564939848
Market cap (USD): 47006198.63333333
Debt to equity: 0.37034828662621444
Current ratio: 0.9648305578199605
Quick ratio: 0.959735646908117
Effective tax rate (%): 68.5
Interest coverage ratio: 10.477801268498945
COGS to revenue (%): 75.84689145641752
SG&A to revenue (%): 1.160889727265582
Free cash flow (dilution-adjusted): 9846666.666666666
Buyback yield (%): 0
Retained earnings: 1056666.6666666667
Inventory turnover: 551.4285714285714
Receivables turnover: 9.446135570569455
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.410179397678382
FCF margin (%): 6.965338363593491
Revenue growth (%): 12.92802592517052
Rule of 40 score: 19.893364288764012
Financial ratios for CTAC.AS — annual report dated 2024-12-31
Total revenue: 129511458.33333334
Gross profit: 26984375
Operating income: 5788541.666666667
Net income: 4072916.666666667
Capital expenditures: 1877083.3333333335
Operating cash flow: 10711458.333333334
Depreciation & amortization: 5390625
Net tangible assets: 4216666.666666667
Owner earnings: 7586458.333333334
Return on net tangible assets (%): 179.91600790513834
Capex to operating income (%): 32.42756883210365
Buffett classification: The Good
Stock price: 2.895833333333333
P/E ratio: 10.059919166240407
Shares outstanding: 14149023
Book value: 32151041.66666667
P/B ratio: 1.2743976653167015
Market cap (USD): 40973212.43749999
Debt to equity: 0.28443220476267617
Current ratio: 1.0087024133496816
Quick ratio: 1.0061305661054456
Effective tax rate (%): 24.327462744339073
Interest coverage ratio: 14.24871794871795
COGS to revenue (%): 79.16448834160427
SG&A to revenue (%): 1.0986801360883447
Free cash flow (dilution-adjusted): 7289583.333333334
Buyback yield (%): 0
Retained earnings: 4072916.666666667
Inventory turnover: 1144.4883720930231
Receivables turnover: 8.887133666904932
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.425897562368577
FCF margin (%): 5.628523859697099
Revenue growth (%): -8.386141240273506
Rule of 40 score: -2.7576173805764075
Financial ratios for CTAC.AS — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 5021176.470588235
Buffett classification: The Gruesome
Stock price: 3.7882352941176474
Shares outstanding: 14149023
Book value: 36137647.058823526
P/B ratio: 1.4832130110362343
Market cap (USD): 53599828.30588236
Debt to equity: 0.4477650812253801
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVE.TO — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 3403149606.2992125
Buffett classification: The Gruesome
Stock price: 10.803149606299213
Shares outstanding: 1864819000
Market cap (USD): 20145918645.669292
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVE.TO — annual report dated 2022-12-31
Total revenue: 52768382352.94117
Gross profit: 12598529411.764706
Operating income: 7611764705.882353
Net income: 4742647058.823529
Capital expenditures: 36764705.88235294
Operating cash flow: 8384558823.529411
Depreciation & amortization: 3440441176.470588
Net tangible assets: 18113235294.117645
Owner earnings: 8146323529.411764
Return on net tangible assets (%): 44.97442559064708
Capex to operating income (%): 0.4829984544049459
Buffett classification: The Great
Stock price: 17.39705882352941
P/E ratio: 6.840560858914728
Shares outstanding: 1864819000
Book value: 20286029411.7647
P/B ratio: 1.5992467120954004
Market cap (USD): 32442365838.23529
Debt to equity: 0.4219797745478271
Current ratio: 1.5496820845281136
Quick ratio: 1.0120932552050865
Effective tax rate (%): 26.125300652846185
Interest coverage ratio: 12.748768472906406
COGS to revenue (%): 76.12485194732808
SG&A to revenue (%): 1.2053229290043892
Free cash flow (dilution-adjusted): 5621323529.411764
Buyback yield (%): 5.734150607026907
Retained earnings: 4700000000
Inventory turnover: 12.669526901669759
Receivables turnover: 22.482769423558896
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 21.63517806386892
FCF margin (%): 10.652825193339371
Rule of 40 score: 10.652825193339371
Financial ratios for CVE.TO — annual report dated 2023-12-31
Total revenue: 42025757575.757576
Gross profit: 9624242424.242424
Operating income: 4259090909.090909
Net income: 3112878787.8787875
Capital expenditures: 0
Operating cash flow: 5596969696.969697
Depreciation & amortization: 3518181818.181818
Net tangible assets: 19526515151.515152
Owner earnings: 6631060606.060606
Return on net tangible assets (%): 33.959262851600386
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 15.401515151515149
P/E ratio: 9.226519900219031
Shares outstanding: 1864819000
Book value: 21751515151.515152
P/B ratio: 1.3204155151156307
Market cap (USD): 28721038083.33333
Debt to equity: 0.34637085539147394
Current ratio: 1.5632850241545895
Quick ratio: 0.9143317230273752
Effective tax rate (%): 18.47222222222222
Interest coverage ratio: 7.775933609958506
COGS to revenue (%): 77.09918159858672
SG&A to revenue (%): 1.2402206439052528
Free cash flow (dilution-adjusted): 2350000000
Buyback yield (%): 2.798603157921067
Retained earnings: 6752272727.272727
Inventory turnover: 10.61290322580645
Receivables turnover: 17.287005297600498
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.784928204590713
FCF margin (%): 5.591808775282114
Revenue growth (%): -20.358071061059974
Rule of 40 score: -14.76626228577786
Financial ratios for CVE.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.829629629629629
Shares outstanding: 1864819000
Market cap (USD): 29519394096.296295
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVE.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 14.517482517482518
Shares outstanding: 1864819000
Market cap (USD): 27072477230.769234
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVE.TO — annual report dated 2024-12-31
Total revenue: 40367832167.83217
Gross profit: 8926573426.573427
Operating income: 3539160839.160839
Net income: 2197202797.2027974
Capital expenditures: 3506993006.993007
Operating cash flow: 6458041958.041958
Depreciation & amortization: 3406293706.2937064
Net tangible assets: 18755244755.244755
Owner earnings: 2096503496.5034966
Return on net tangible assets (%): 11.178225205070843
Capex to operating income (%): 99.09108871764474
Buffett classification: The Gruesome
Stock price: 14.517482517482518
P/E ratio: 12.321337504774029
Shares outstanding: 1864819000
Book value: 20817482517.482517
P/B ratio: 1.3004683543283282
Market cap (USD): 27072477230.769234
Debt to equity: 0.3572172394101247
Current ratio: 1.417277913610432
Quick ratio: 0.8065743004618312
Effective tax rate (%): 22.81994595922378
Interest coverage ratio: 7.798151001540831
COGS to revenue (%): 77.88691404219936
SG&A to revenue (%): 1.3754633960433773
Free cash flow (dilution-adjusted): 3052447552.4475527
Buyback yield (%): 4.4893734881537535
Retained earnings: 7351748251.748252
Inventory turnover: 10.000222419928827
Receivables turnover: 21.71783295711061
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.291396384488683
FCF margin (%): 7.561584034923604
Revenue growth (%): -3.945022061617222
Rule of 40 score: 3.6165619733063825
Financial ratios for CVE.TO — quarterly report dated 2025-03-31
Total revenue: 9933566433.566435
Gross profit: 2174825174.825175
Operating income: 897902097.902098
Net income: 600699300.6993008
Capital expenditures: 859440559.4405595
Operating cash flow: 919580419.5804197
Depreciation & amortization: 918881118.8811189
Net tangible assets: 18957342657.34266
Owner earnings: 660139860.13986
Return on net tangible assets (%): 3.4822383710206934
Capex to operating income (%): 95.7165109034268
Buffett classification: The Gruesome
Stock price: 13.454545454545453
P/E ratio: 10.442118032596039
Shares outstanding: 1864819000
Book value: 21011888111.88811
P/B ratio: 1.194099828934669
Market cap (USD): 25090291999.999996
Debt to equity: 0.35850500881951614
Current ratio: 1.462083936324168
Quick ratio: 0.8374819102749638
Effective tax rate (%): 23.982300884955755
Interest coverage ratio: 7.877300613496932
COGS to revenue (%): 78.10630059838084
SG&A to revenue (%): 1.3868356212601194
Free cash flow (dilution-adjusted): 55244755.24475525
Buyback yield (%): 0.730229776587627
Retained earnings: 7719580419.58042
Inventory turnover: 2.570667284522706
Receivables turnover: 4.705200397482611
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.5955124317768345
FCF margin (%): 0.5561422034494896
Rule of 40 score: 0.5561422034494896
Financial ratios for CVE.TO — quarterly report dated 2025-06-30
Total revenue: 8991970802.919708
Gross profit: 1893430656.9343064
Operating income: 503649635.0364963
Net income: 621167883.2116787
Capital expenditures: 849635036.4963503
Operating cash flow: 1732846715.3284671
Depreciation & amortization: 864233576.6423357
Net tangible assets: 19327737226.27737
Owner earnings: 635766423.3576641
Return on net tangible assets (%): 3.289399146493447
Capex to operating income (%): 168.69565217391306
Buffett classification: The Gruesome
Stock price: 13.145985401459853
P/E ratio: 20.063459984167167
Shares outstanding: 1864819000
Book value: 21472262773.722626
P/B ratio: 1.1417000438521943
Market cap (USD): 24514883350.364964
Debt to equity: 0.35646055002209603
Current ratio: 1.3239988798655837
Quick ratio: 0.7755530663679641
Effective tax rate (%): 16.240157480314963
Interest coverage ratio: 4.48051948051948
COGS to revenue (%): 78.94309603052196
SG&A to revenue (%): 1.2419839272668236
Free cash flow (dilution-adjusted): 874452554.7445254
Buyback yield (%): 1.3875080723008864
Retained earnings: 8410218978.102189
Inventory turnover: 2.482767424049017
Receivables turnover: 4.139448924731183
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4174781215333416
FCF margin (%): 9.72481532591931
Revenue growth (%): -9.478928207144097
Rule of 40 score: 0.2458871187752134
Financial ratios for CVE.TO — quarterly report dated 2025-09-30
Total revenue: 9492805755.395683
Gross profit: 2393525179.8561153
Operating income: 1088489208.6330936
Net income: 925179856.115108
Capital expenditures: 830215827.3381295
Operating cash flow: 1533093525.1798563
Depreciation & amortization: 951079136.6906476
Net tangible assets: 18310071942.446045
Owner earnings: 1046043165.4676261
Return on net tangible assets (%): 5.71293858787474
Capex to operating income (%): 76.27230667547917
Buffett classification: The Gruesome
Stock price: 16.661870503597125
P/E ratio: 14.471677663042707
Shares outstanding: 1864819000
Book value: 20423741007.19425
P/B ratio: 1.52133601183557
Market cap (USD): 31071372690.647488
Debt to equity: 0.35323540808059456
Current ratio: 1.7287205804282426
Quick ratio: 1.1755441514776144
Effective tax rate (%): 0.8481110254433308
Interest coverage ratio: 9.575949367088608
COGS to revenue (%): 74.785903751421
SG&A to revenue (%): 1.6672982190223573
Free cash flow (dilution-adjusted): 648920863.3093525
Buyback yield (%): 2.174154245038108
Retained earnings: 8797841726.618706
Inventory turnover: 3.1567498400511833
Receivables turnover: 2.782581189371573
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.1572138057677055
FCF margin (%): 6.8359226979916645
Revenue growth (%): 5.569801809335869
Rule of 40 score: 12.405724507327534
Financial ratios for CVE.TO — quarterly report dated 2025-12-31
Total revenue: 10173722627.737225
Gross profit: 2035036496.350365
Operating income: 832116788.3211678
Net income: 681751824.8175182
Capital expenditures: 992700729.9270072
Operating cash flow: 1757664233.5766423
Depreciation & amortization: 1001459854.0145985
Net tangible assets: 20939416058.394157
Owner earnings: 690510948.9051094
Return on net tangible assets (%): 3.2976609614110926
Capex to operating income (%): 119.29824561403508
Buffett classification: The Gruesome
Stock price: 16.751824817518248
P/E ratio: 11.043245807476898
Shares outstanding: 1864819000
Book value: 23093430656.934303
P/B ratio: 1.3527276076237438
Market cap (USD): 31239121204.379562
Debt to equity: 0.44904861242809285
Current ratio: 1.566360468799493
Quick ratio: 1.0359518530250236
Effective tax rate (%): 9.671179883945841
Interest coverage ratio: 6.129032258064516
COGS to revenue (%): 79.9971301477974
SG&A to revenue (%): 1.7362605825799973
Free cash flow (dilution-adjusted): 714598540.1459854
Buyback yield (%): 1.8108493736297133
Retained earnings: 8994890510.948904
Inventory turnover: 3.3293520453866825
Receivables turnover: 3.9361762214063822
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9961477849763616
FCF margin (%): 7.0239632658918065
Revenue growth (%): 7.172978041339465
Rule of 40 score: 14.19694130723127
Financial ratios for CVE.TO — annual report dated 2025-12-31
Total revenue: 38504379562.04379
Gross profit: 8624817518.248175
Operating income: 3377372262.773722
Net income: 2868613138.686131
Capital expenditures: 3581751824.8175178
Operating cash flow: 6005839416.0583935
Depreciation & amortization: 3789781021.89781
Net tangible assets: 20939416058.394157
Owner earnings: 3076642335.7664227
Return on net tangible assets (%): 14.693066545822148
Capex to operating income (%): 106.05143721633887
Buffett classification: The Gruesome
Stock price: 16.751824817518248
P/E ratio: 10.889973549618322
Shares outstanding: 1864819000
Book value: 23093430656.934303
P/B ratio: 1.3527276076237438
Market cap (USD): 31239121204.379562
Debt to equity: 0.44904861242809285
Current ratio: 1.566360468799493
Quick ratio: 1.0359518530250236
Effective tax rate (%): 12.218003127094034
Interest coverage ratio: 7
COGS to revenue (%): 77.60042463649978
SG&A to revenue (%): 1.5393073117097305
Free cash flow (dilution-adjusted): 2305109489.0510945
Buyback yield (%): 5.841449592353914
Retained earnings: 8994890510.948904
Inventory turnover: 12.223051657211109
Receivables turnover: 14.89720417961028
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.10190859744353
FCF margin (%): 5.9866163674622275
Revenue growth (%): -4.6161820085877725
Rule of 40 score: 1.370434358874455
Financial ratios for CXM — annual report dated 2022-01-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.25
Shares outstanding: 133099276
Market cap (USD): 1497366855
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CXM — annual report dated 2023-01-31
Total revenue: 618190000
Gross profit: 454465000
Operating income: -51224000
Net income: -55742000
Capital expenditures: 6091000
Operating cash flow: 26660000
Depreciation & amortization: 12051000
Net tangible assets: 498983000
Owner earnings: -49782000
Return on net tangible assets (%): -9.97669259273362
Buffett classification: The Gruesome
Stock price: 9.94
Shares outstanding: 133099276
Book value: 549332000
P/B ratio: 2.408392016922371
Market cap (USD): 1323006803.4399998
Debt to equity: 0.030522525540110534
Current ratio: 1.8795617336276609
Quick ratio: 1.8795617336276609
COGS to revenue (%): 26.484575939436095
R&D to revenue (%): 12.400394700658374
SG&A to revenue (%): 69.40115498471344
Free cash flow (dilution-adjusted): -45306000
Buyback yield (%): 0
Retained earnings: -496611000
Receivables turnover: 2.9139288239453216
Capitalized R&D asset: 76658000
ROCI (R&D-adjusted, %): -0.018462336315312005
FCF margin (%): -7.328814765686925
Rule of 40 score: -7.328814765686925
Financial ratios for CXM — annual report dated 2024-01-31
Total revenue: 732360000
Gross profit: 552959000
Operating income: 38215000
Net income: 51403000
Capital expenditures: 8548000
Operating cash flow: 71465000
Depreciation & amortization: 15466000
Net tangible assets: 629559000
Owner earnings: 58321000
Return on net tangible assets (%): 9.263786237667954
Capex to operating income (%): 22.368180034018057
Buffett classification: The Great
Stock price: 12.48
P/E ratio: 32.31482529190903
Shares outstanding: 133099276
Book value: 679704000
P/B ratio: 2.4438269665619154
Market cap (USD): 1661078964.48
Debt to equity: 0.04898014429810624
Current ratio: 1.9698047858942065
Quick ratio: 1.9698047858942065
Effective tax rate (%): 15.067248273355144
COGS to revenue (%): 24.49628597957289
R&D to revenue (%): 12.46545414823311
SG&A to revenue (%): 57.8201977169698
Free cash flow (dilution-adjusted): -4617000
Buyback yield (%): 1.6064257371625565
Retained earnings: -474787000
Receivables turnover: 2.657155918699069
Capitalized R&D asset: 142652860
ROCI (R&D-adjusted, %): 8.573160153251665
Rosenberg metric: 1.284849591692974
FCF margin (%): -0.6304276585285925
Revenue growth (%): 18.468432035458353
Rule of 40 score: 17.83800437692976
Financial ratios for CXM — quarterly report dated 2024-10-31
Capital expenditures: 0
Depreciation & amortization: 1405000
Buffett classification: The Gruesome
Stock price: 7.43
Shares outstanding: 133099276
Market cap (USD): 988927620.68
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CXM — annual report dated 2025-01-31
Total revenue: 796394000
Gross profit: 574638000
Operating income: 26791000
Net income: 121609000
Capital expenditures: 5802000
Operating cash flow: 77590000
Depreciation & amortization: 18679000
Net tangible assets: 562106000
Owner earnings: 134486000
Return on net tangible assets (%): 23.925380622160233
Capex to operating income (%): 21.656526445448097
Buffett classification: The Great
Stock price: 8.91
P/E ratio: 9.751864986637502
Shares outstanding: 133099276
Book value: 612063000
P/B ratio: 1.9375694155013454
Market cap (USD): 1185914549.16
Debt to equity: 0.07957514177462124
Current ratio: 1.6501643214711457
Quick ratio: 1.6501643214711457
Effective tax rate (%): -151.8201772550319
COGS to revenue (%): 27.84501138883517
R&D to revenue (%): 11.50448145013649
SG&A to revenue (%): 57.28646875792636
Free cash flow (dilution-adjusted): -360000
Buyback yield (%): 23.093822416968244
Retained earnings: -626065000
Receivables turnover: 2.7699119353357724
Capitalized R&D asset: 178083780
ROCI (R&D-adjusted, %): 3.7751085164640776
Rosenberg metric: 0.2374687814923542
FCF margin (%): -0.04520375592985382
Revenue growth (%): 8.743514118739418
Rule of 40 score: 8.698310362809563
Financial ratios for CXM — quarterly report dated 2025-01-31
Total revenue: 202539000
Gross profit: 143723000
Operating income: 10459000
Net income: 98679000
Capital expenditures: 802000
Operating cash flow: 5365000
Depreciation & amortization: 4864000
Net tangible assets: 562106000
Owner earnings: 102741000
Return on net tangible assets (%): 18.277869298673206
Capex to operating income (%): 7.668037097236829
Buffett classification: The Great
Stock price: 8.91
P/E ratio: 3.004475494178093
Shares outstanding: 133099276
Book value: 612063000
P/B ratio: 1.9375694155013454
Market cap (USD): 1185914549.16
Debt to equity: 0.07957514177462124
Current ratio: 1.6501643214711457
Quick ratio: 1.6501643214711457
Effective tax rate (%): -541.9398907103825
COGS to revenue (%): 29.03934550876621
R&D to revenue (%): 11.137608065607116
SG&A to revenue (%): 54.659102691333516
Free cash flow (dilution-adjusted): -13799000
Buyback yield (%): 0
Retained earnings: -626065000
Receivables turnover: 0.7044442744055983
Capitalized R&D asset: 22558000
ROCI (R&D-adjusted, %): 3.6997429773419586
FCF margin (%): -6.81300885261604
Rule of 40 score: -6.81300885261604
Financial ratios for CXM — quarterly report dated 2025-04-30
Total revenue: 205500000
Gross profit: 142869000
Operating income: 14558000
Net income: -1568000
Capital expenditures: 289000
Operating cash flow: 83776000
Depreciation & amortization: 4679000
Net tangible assets: 589628000
Owner earnings: 2822000
Capex to operating income (%): 1.985162797087512
Buffett classification: The Great
Stock price: 7.69
Shares outstanding: 133099276
Book value: 639772000
P/B ratio: 1.5998409315193538
Market cap (USD): 1023533432.44
Debt to equity: 0.07957834978711166
Current ratio: 1.7400546938857886
Quick ratio: 1.7400546938857886
Effective tax rate (%): 130.29951690821255
COGS to revenue (%): 30.477372262773724
R&D to revenue (%): 11.100243309002433
SG&A to revenue (%): 51.338199513382
Free cash flow (dilution-adjusted): 59421000
Buyback yield (%): 0
Retained earnings: -627633000
Receivables turnover: 0.9894697308931228
Capitalized R&D asset: 37924860
ROCI (R&D-adjusted, %): 3.039287525207055
Rosenberg metric: -0.03785796613174927
FCF margin (%): 28.915328467153284
Revenue growth (%): 1.4619406632796645
Rule of 40 score: 30.37726913043295
Financial ratios for CXM — quarterly report dated 2025-07-31
Total revenue: 212040000
Gross profit: 144602000
Operating income: 15288000
Net income: 12615000
Capital expenditures: 365000
Operating cash flow: 34791000
Depreciation & amortization: 4669000
Net tangible assets: 493282000
Owner earnings: 16919000
Return on net tangible assets (%): 3.4298839203538747
Capex to operating income (%): 2.3874934589220307
Buffett classification: The Great
Stock price: 9.01
P/E ratio: 10.929264502123472
Shares outstanding: 133099276
Book value: 543437000
P/B ratio: 2.2067405729827008
Market cap (USD): 1199224476.76
Debt to equity: 0.0887168153806237
Current ratio: 1.5532268122221233
Quick ratio: 1.5532268122221233
Effective tax rate (%): 46.864074807295395
COGS to revenue (%): 31.804376532729673
R&D to revenue (%): 10.923410677230711
SG&A to revenue (%): 50.062252405206564
Free cash flow (dilution-adjusted): 8187000
Buyback yield (%): 11.744673556074124
Retained earnings: -756446000
Receivables turnover: 1.0085232677599787
Capitalized R&D asset: 45889510
ROCI (R&D-adjusted, %): 2.44583277586536
Rosenberg metric: 0.07597211871465522
FCF margin (%): 3.861063950198076
Revenue growth (%): 3.182481751824817
Rule of 40 score: 7.043545702022893
Financial ratios for CXM — quarterly report dated 2025-10-31
Total revenue: 219068000
Gross profit: 145486000
Operating income: 12081000
Net income: 2904000
Capital expenditures: 185000
Operating cash flow: 19961000
Depreciation & amortization: 4778000
Net tangible assets: 507909000
Owner earnings: 7497000
Return on net tangible assets (%): 1.476051812430967
Capex to operating income (%): 1.5313301878983527
Buffett classification: The Great
Stock price: 7.72
P/E ratio: 9.1230259319897
Shares outstanding: 133099276
Book value: 558085000
P/B ratio: 1.8411647163424925
Market cap (USD): 1027526410.7199999
Debt to equity: 0.08678964673840006
Current ratio: 1.6566095351335284
Quick ratio: 1.6566095351335284
Effective tax rate (%): 83.2274459974587
COGS to revenue (%): 33.58865740318075
R&D to revenue (%): 11.278233242646118
SG&A to revenue (%): 49.618383333029016
Free cash flow (dilution-adjusted): -4862000
Buyback yield (%): 1.1112123134625098
Retained earnings: -763455000
Receivables turnover: 1.3262621309262186
Capitalized R&D asset: 47753170
ROCI (R&D-adjusted, %): 2.0116208972981915
Rosenberg metric: 0.03816596148864519
FCF margin (%): -2.2194021947523144
Revenue growth (%): 3.3144689681192228
Rule of 40 score: 1.0950667733669084
Financial ratios for CXM — quarterly report dated 2026-01-31
Total revenue: 220592000
Gross profit: 144826000
Operating income: 15097000
Net income: 8954000
Capital expenditures: 540000
Operating cash flow: 20665000
Depreciation & amortization: 4938000
Net tangible assets: 542499000
Owner earnings: 13352000
Return on net tangible assets (%): 2.4612026934611864
Capex to operating income (%): 3.5768695767371
Buffett classification: The Great
Stock price: 6.38
P/E ratio: 37.073712328312595
Shares outstanding: 133099276
Book value: 592643000
P/B ratio: 1.4328581977345551
Market cap (USD): 849173380.88
Debt to equity: 0.07885354252053935
Current ratio: 1.6025887444481142
Quick ratio: 1.6025887444481142
Effective tax rate (%): 56.44729802033173
COGS to revenue (%): 34.346667150213975
R&D to revenue (%): 11.478657430913179
SG&A to revenue (%): 47.33081888735766
Free cash flow (dilution-adjusted): -5277000
Buyback yield (%): 0
Retained earnings: -754309000
Receivables turnover: 0.764190521061037
Capitalized R&D asset: 49518150
ROCI (R&D-adjusted, %): 2.287166932564574
Rosenberg metric: -0.026713077265552273
FCF margin (%): -2.392199173134112
Revenue growth (%): 0.6956744024686399
Rule of 40 score: -1.6965247706654722
Financial ratios for CXM — annual report dated 2026-01-31
Total revenue: 857200000
Gross profit: 577783000
Operating income: 57024000
Net income: 22905000
Capital expenditures: 1379000
Operating cash flow: 159193000
Depreciation & amortization: 19064000
Net tangible assets: 542499000
Owner earnings: 40590000
Return on net tangible assets (%): 7.482041441551044
Capex to operating income (%): 2.418280022446689
Buffett classification: The Great
Stock price: 6.38
P/E ratio: 37.073712328312595
Shares outstanding: 133099276
Book value: 592643000
P/B ratio: 1.4328581977345551
Market cap (USD): 849173380.88
Debt to equity: 0.07885354252053935
Current ratio: 1.6025887444481142
Quick ratio: 1.6025887444481142
Effective tax rate (%): 65.70543053496833
COGS to revenue (%): 32.596476901539894
R&D to revenue (%): 11.1993700419972
SG&A to revenue (%): 49.551796546896874
Free cash flow (dilution-adjusted): 57469000
Buyback yield (%): 17.930731630118878
Retained earnings: -754309000
Receivables turnover: 2.969573305711544
Capitalized R&D asset: 187513430
ROCI (R&D-adjusted, %): 7.162176915847541
Rosenberg metric: 0.03432619159363028
FCF margin (%): 6.70426971535231
Revenue growth (%): 7.635165508529698
Rule of 40 score: 14.339435223882008
Financial ratios for EARN — annual report dated 2021-12-31
Total revenue: -557000
Net income: -6309000
Capital expenditures: 0
Operating cash flow: 27880000
Net tangible assets: 154225000
Owner earnings: -6309000
Return on net tangible assets (%): -4.090776462959961
Buffett classification: The Gruesome
Stock price: 5.27
Shares outstanding: 37568800
Book value: 154225000
P/B ratio: 1.2837579899497487
Market cap (USD): 197987575.99999997
Debt to equity: 0
Free cash flow (dilution-adjusted): 27609000
Buyback yield (%): 0
Retained earnings: -84771000
Receivables turnover: -0.005978575875319322
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EARN — annual report dated 2022-12-31
Total revenue: -25070000
Net income: -30198000
Capital expenditures: 0
Operating cash flow: 22417000
Net tangible assets: 112409000
Owner earnings: -30198000
Return on net tangible assets (%): -26.864396978889594
Buffett classification: The Gruesome
Stock price: 3.95
Shares outstanding: 37568800
Book value: 112409000
P/B ratio: 1.3201501659119823
Market cap (USD): 148396760
Debt to equity: 0
Free cash flow (dilution-adjusted): 22105000
Buyback yield (%): 0.17655371990601412
Retained earnings: -128665000
Receivables turnover: -0.45088306176036835
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EARN — annual report dated 2023-12-31
Total revenue: 10094000
Net income: 4559000
Capital expenditures: 0
Operating cash flow: -10022000
Net tangible assets: 136238000
Owner earnings: 4559000
Return on net tangible assets (%): 3.346349770254995
Buffett classification: The Gruesome
Stock price: 4.07
P/E ratio: 33.53915683263874
Shares outstanding: 37568800
Book value: 136238000
P/B ratio: 1.1223374976144689
Market cap (USD): 152905016
Debt to equity: 0
Effective tax rate (%): 0
COGS to revenue (%): 0
SG&A to revenue (%): 11.065979789974243
Free cash flow (dilution-adjusted): -10277000
Buyback yield (%): 0
Retained earnings: -138646000
Receivables turnover: 0.17137812186964124
Capitalized R&D asset: 0
FCF margin (%): -101.81295819298593
Rule of 40 score: -101.81295819298593
Financial ratios for EARN — quarterly report dated 2024-09-30
Total revenue: 8633000
Net income: 5445000
Capital expenditures: 0
Operating cash flow: 3241000
Net tangible assets: 191629000
Owner earnings: 5445000
Return on net tangible assets (%): 2.841427967583195
Buffett classification: The Gruesome
Stock price: 5.15
P/E ratio: 8.883348025711662
Shares outstanding: 37568800
Book value: 191629000
P/B ratio: 1.009655741041283
Market cap (USD): 193479320
Debt to equity: 0
Effective tax rate (%): 7.836831415030467
COGS to revenue (%): 0
SG&A to revenue (%): 6.880574539557512
Free cash flow (dilution-adjusted): 2939000
Buyback yield (%): 0
Retained earnings: -146174000
Receivables turnover: 0.1453660672189668
Capitalized R&D asset: 0
FCF margin (%): 34.043785474342634
Rule of 40 score: 34.043785474342634
Financial ratios for EARN — quarterly report dated 2024-12-31
Total revenue: 83000
Net income: -2005000
Capital expenditures: 0
Operating cash flow: 4406000
Net tangible assets: 193726000
Owner earnings: -2005000
Return on net tangible assets (%): -1.0349669120303935
Buffett classification: The Gruesome
Stock price: 5.07
Shares outstanding: 37568800
Book value: 193726000
P/B ratio: 0.9832124547040666
Market cap (USD): 190473816
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 537.3493975903615
Free cash flow (dilution-adjusted): 4409000
Buyback yield (%): 0
Retained earnings: -155159000
Receivables turnover: 0.0019244145606306514
Capitalized R&D asset: 0
FCF margin (%): 5312.048192771084
Revenue growth (%): -99.03857291787328
Rule of 40 score: 5213.009619853211
Financial ratios for EARN — annual report dated 2024-12-31
Total revenue: 15880000
Net income: 6586000
Capital expenditures: 0
Operating cash flow: 9112000
Net tangible assets: 193726000
Owner earnings: 6586000
Return on net tangible assets (%): 3.39964692400607
Buffett classification: The Gruesome
Stock price: 5.07
P/E ratio: 28.921016702095358
Shares outstanding: 37568800
Book value: 193726000
P/B ratio: 0.9832124547040666
Market cap (USD): 190473816
Debt to equity: 0
Effective tax rate (%): 7.187147688838783
COGS to revenue (%): 0
SG&A to revenue (%): 12.122166246851386
Free cash flow (dilution-adjusted): 8670000
Buyback yield (%): 0
Retained earnings: -155159000
Receivables turnover: 0.36818919545559936
Capitalized R&D asset: 0
FCF margin (%): 54.59697732997482
Revenue growth (%): 57.32118089954429
Rule of 40 score: 111.91815822951911
Financial ratios for EARN — quarterly report dated 2025-03-31
Total revenue: -5294000
Net income: -7870000
Capital expenditures: 0
Operating cash flow: 9211000
Net tangible assets: 228501000
Owner earnings: -7870000
Return on net tangible assets (%): -3.4441862398851644
Buffett classification: The Gruesome
Stock price: 4.3
Shares outstanding: 37568800
Book value: 228501000
P/B ratio: 0.7069808884862648
Market cap (USD): 161545840
Debt to equity: 0
Free cash flow (dilution-adjusted): 9008000
Buyback yield (%): 0.606019938365482
Retained earnings: -171744000
Receivables turnover: -0.4787484174353409
Capitalized R&D asset: 0
Revenue growth (%): -6478.313253012048
Rule of 40 score: -6478.313253012048
Financial ratios for ECR.L — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.0002702702702702703
Shares outstanding: 3601490394
Market cap (USD): 973375.7821621621
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ECR.L — annual report dated 2022-09-30
Total revenue: 0
Operating income: -1349331.111111111
Net income: -2905414.4444444445
Capital expenditures: 1861925.5555555555
Operating cash flow: -1020150
Depreciation & amortization: 115738.88888888889
Net tangible assets: 6498982.222222222
Owner earnings: -4651601.111111111
Return on net tangible assets (%): -71.57430120682145
Buffett classification: The Gruesome
Stock price: 0.00011111111111111112
Shares outstanding: 3601490394
Book value: 6498982.222222222
P/B ratio: 0.06157357962374964
Market cap (USD): 400165.5993333334
Debt to equity: 0
Current ratio: 5.354342861566449
Quick ratio: 5.012560236883358
Free cash flow (dilution-adjusted): -2980557.7777777775
Buyback yield (%): 0
Retained earnings: -66517711.11111111
Inventory turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -20.762191139672467
Rule of 40 score: 0
Financial ratios for ECR.L — annual report dated 2023-09-30
Total revenue: 0
Operating income: -1800898.780487805
Net income: -2161792.6829268294
Capital expenditures: 534130.487804878
Operating cash flow: -1443356.0975609757
Depreciation & amortization: 160415.8536585366
Net tangible assets: 6112686.585365854
Owner earnings: -2535507.317073171
Return on net tangible assets (%): -41.47942613552821
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 3601490394
Book value: 6112686.585365854
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0
Current ratio: 1.1566115729294424
Quick ratio: 1.1566115729294424
Free cash flow (dilution-adjusted): -2789184.1463414636
Retained earnings: -75169036.58536586
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -29.461657412622248
Rule of 40 score: 0
Financial ratios for ECR.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 6987394.666666667
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 3601490394
Book value: 6987394.666666667
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0
Current ratio: 3.916200765720879
Quick ratio: 3.916200765720879
Retained earnings: -83762388
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ECR.L — annual report dated 2024-09-30
Total revenue: 0
Operating income: -1428894.6666666667
Net income: -1577574.6666666667
Capital expenditures: 216094.66666666666
Operating cash flow: -1079213.3333333333
Depreciation & amortization: 82858.66666666667
Net tangible assets: 6987394.666666667
Owner earnings: -1710810.6666666667
Return on net tangible assets (%): -24.48424267242383
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 3601490394
Book value: 6987394.666666667
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0
Current ratio: 3.916200765720879
Quick ratio: 3.916200765720879
Free cash flow (dilution-adjusted): -2077393.3333333333
Retained earnings: -83762388
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -20.449605823515334
Rule of 40 score: 0
Financial ratios for ECR.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 7170084.415584415
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 3601490394
Book value: 7170084.415584415
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0
Current ratio: 11.58305197525692
Quick ratio: 11.58305197525692
Retained earnings: -82107168.83116883
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ECR.L — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 6974379.72972973
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 3601490394
Book value: 6974379.72972973
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0
Current ratio: 2.974778445271305
Quick ratio: 2.974778445271305
Retained earnings: -86403333.78378378
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ECR.L — annual report dated 2025-09-30
Total revenue: 0
Operating income: -1687491.8918918918
Net income: -1756086.4864864864
Capital expenditures: 6871.621621621622
Operating cash flow: -1158539.189189189
Depreciation & amortization: 16767.567567567567
Net tangible assets: 6974379.72972973
Owner earnings: -1746190.5405405404
Return on net tangible assets (%): -25.037216329031292
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 3601490394
Book value: 6974379.72972973
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0
Current ratio: 2.974778445271305
Quick ratio: 2.974778445271305
Free cash flow (dilution-adjusted): -2127010.810810811
Retained earnings: -86403333.78378378
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -24.195583797919838
Rule of 40 score: 0
Financial ratios for ELABS.OL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.1641961231470925
Shares outstanding: 126336765
Market cap (USD): 399754302.0239453
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ELABS.OL — annual report dated 2022-12-31
Total revenue: 5269433.198380566
Gross profit: -1087044.5344129554
Operating income: -4264271.255060729
Net income: -3339979.75708502
Capital expenditures: 0
Operating cash flow: -1755161.943319838
Depreciation & amortization: 1145445.3441295545
Net tangible assets: 28142408.906882588
Owner earnings: -2194534.4129554657
Return on net tangible assets (%): -7.797962215021202
Buffett classification: The Gruesome
Stock price: 2.2317813765182186
Shares outstanding: 126336765
Book value: 32957591.093117405
P/B ratio: 8.555116740781463
Market cap (USD): 281956039.2965587
Debt to equity: 0.0390238958789513
Current ratio: 13.133418708888758
Quick ratio: 13.133418708888758
Interest coverage ratio: -34.11417004048583
COGS to revenue (%): 120.6292497406938
SG&A to revenue (%): 21.820137528331607
Free cash flow (dilution-adjusted): -5377732.793522267
Buyback yield (%): 0
Receivables turnover: 1.2856402024941351
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.684520314922699
FCF margin (%): -102.05524182705237
Rule of 40 score: -102.05524182705237
Financial ratios for ELABS.OL — annual report dated 2023-12-31
Total revenue: 6711296.660117879
Gross profit: -1201473.47740668
Operating income: -5529666.01178782
Net income: -3744007.858546169
Capital expenditures: 50491.15913555992
Operating cash flow: -3742632.6129666013
Depreciation & amortization: 1593713.163064833
Net tangible assets: 24535854.616895873
Owner earnings: -2200785.854616896
Return on net tangible assets (%): -8.969672705434892
Buffett classification: The Gruesome
Stock price: 1.6738703339882122
Shares outstanding: 126336765
Book value: 30000294.695481334
P/B ratio: 7.048976190803627
Market cap (USD): 211471363.02554026
Debt to equity: 0.08468810064079267
Current ratio: 7.447725266789697
Quick ratio: 7.447725266789697
Interest coverage ratio: -28.94190231362468
COGS to revenue (%): 117.9022555290467
SG&A to revenue (%): 24.58394929816601
Free cash flow (dilution-adjusted): -7225442.043222005
Buyback yield (%): 0
Receivables turnover: 1.1271860357684949
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -17.412930706483916
FCF margin (%): -107.66089489322464
Revenue growth (%): 27.362780918836478
Rule of 40 score: -80.29811397438816
Financial ratios for ELABS.OL — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.2767175572519085
Shares outstanding: 126336765
Market cap (USD): 161296366.00190842
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ELABS.OL — annual report dated 2024-12-31
Total revenue: 11642894.969108561
Gross profit: 3888172.992056487
Operating income: -27096.20476610768
Net income: 790909.0909090909
Capital expenditures: 0
Operating cash flow: -936187.1138570168
Depreciation & amortization: 1929390.9973521624
Net tangible assets: 22867608.120035306
Owner earnings: 2720300.088261253
Return on net tangible assets (%): 11.895866301285267
Buffett classification: The Gruesome
Stock price: 0.9241622574955909
P/E ratio: 147.6221114273551
Shares outstanding: 126336765
Book value: 28715092.674315974
P/B ratio: 4.066003591606768
Market cap (USD): 116755669.94708996
Debt to equity: 0.0594820219953157
Current ratio: 7.831196409968746
Quick ratio: 7.831196409968746
Effective tax rate (%): 47.43356602334721
Interest coverage ratio: -0.16666666666666666
COGS to revenue (%): 66.60475764513244
SG&A to revenue (%): 9.560016374304471
Free cash flow (dilution-adjusted): -4111562.2241835836
Buyback yield (%): 0
Receivables turnover: 1.1891000216340952
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.09135056000571312
FCF margin (%): -35.313916642661134
Revenue growth (%): 73.48204912914791
Rule of 40 score: 38.168132486486776
Financial ratios for ELABS.OL — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.9241622574955909
Shares outstanding: 126336765
Market cap (USD): 116755669.94708996
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ELABS.OL — quarterly report dated 2025-03-31
Total revenue: 2539885.496183206
Gross profit: 444751.90839694656
Operating income: -659255.7251908396
Net income: -1145229.0076335878
Capital expenditures: 702958.0152671755
Operating cash flow: 1151622.1374045801
Depreciation & amortization: 502290.0763358778
Net tangible assets: 23340362.595419846
Owner earnings: -1345896.9465648853
Return on net tangible assets (%): -5.766392621633885
Buffett classification: The Gruesome
Stock price: 0.8683206106870228
Shares outstanding: 126336765
Book value: 29895324.427480914
P/B ratio: 3.669497456136711
Market cap (USD): 109700816.9370229
Debt to equity: 0.05376903508743932
Current ratio: 7.268213532370599
Quick ratio: 7.268213532370599
Interest coverage ratio: -0.7629196113074204
COGS to revenue (%): 82.48929295965137
SG&A to revenue (%): 15.181456157487416
Free cash flow (dilution-adjusted): 402003.8167938931
Buyback yield (%): 0
Receivables turnover: 0.2880237188365651
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.1324468971647623
FCF margin (%): 15.827635434668272
Rule of 40 score: 15.827635434668272
Financial ratios for ELABS.OL — quarterly report dated 2025-06-30
Total revenue: 2442999.0069513405
Gross profit: 627805.3624627606
Operating income: -489275.0744786494
Net income: -818073.4856007944
Capital expenditures: 3078.4508440913605
Operating cash flow: -921747.7656405164
Depreciation & amortization: 609831.1817279046
Net tangible assets: 23359880.83416087
Owner earnings: -211320.7547169812
Return on net tangible assets (%): -0.904631133254547
Buffett classification: The Gruesome
Stock price: 1.3366434955312811
Shares outstanding: 126336765
Book value: 30383018.86792453
P/B ratio: 5.5579472177462845
Market cap (USD): 168867215.183714
Debt to equity: 0.04758838660334622
Current ratio: 7.84911809815951
Quick ratio: 7.84911809815951
Interest coverage ratio: -0.8169457801359641
COGS to revenue (%): 74.30185764806309
SG&A to revenue (%): 13.198650461363359
Free cash flow (dilution-adjusted): -1781330.6852035748
Buyback yield (%): 0
Receivables turnover: 0.2625562978932314
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.5616085804480393
FCF margin (%): -72.91573513271818
Revenue growth (%): -3.8146006730406095
Rule of 40 score: -76.7303358057588
Financial ratios for ELABS.OL — quarterly report dated 2025-09-30
Total revenue: 4234368.73747495
Gross profit: 1916933.8677354709
Operating income: 643286.5731462926
Net income: 387274.5490981964
Capital expenditures: 0
Operating cash flow: 654108.2164328657
Depreciation & amortization: 650601.2024048095
Net tangible assets: 23953406.813627254
Owner earnings: 1037875.7515030059
Return on net tangible assets (%): 4.33289410386731
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.9288577154308616
P/E ratio: 75.75302791397152
Shares outstanding: 126336765
Book value: 31179959.919839676
P/B ratio: 3.7635994149613077
Market cap (USD): 117348878.91282563
Debt to equity: 0.042310460960999566
Current ratio: 9.660707053173638
Quick ratio: 9.660707053173638
Effective tax rate (%): 29.880261248185775
Interest coverage ratio: 3.0513307984790874
COGS to revenue (%): 54.729170117608085
SG&A to revenue (%): 4.825007690669443
Free cash flow (dilution-adjusted): -193787.57515030057
Buyback yield (%): 0
Receivables turnover: 0.4049658846979455
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.008534708230613
FCF margin (%): -4.57653990865851
Revenue growth (%): 73.3266663402819
Rule of 40 score: 68.7501264316234
Financial ratios for ELABS.OL — annual report dated 2025-12-31
Total revenue: 10080199.004975123
Gross profit: 1081393.0348258705
Operating income: -4700796.019900497
Net income: -13926467.66169154
Capital expenditures: 3084.5771144278606
Operating cash flow: 596417.9104477612
Depreciation & amortization: 2519900.4975124374
Net tangible assets: 11596119.402985074
Owner earnings: -11409651.74129353
Return on net tangible assets (%): -98.3919822208493
Buffett classification: The Gruesome
Stock price: 0.6762948207171315
Shares outstanding: 126336765
Book value: 18705970.14925373
P/B ratio: 4.5675738362635006
Market cap (USD): 85440899.83565737
Debt to equity: 0.06972525865049602
Current ratio: 5.21247732471015
Quick ratio: 5.21247732471015
Interest coverage ratio: -30.697205977907732
COGS to revenue (%): 89.2721062918287
SG&A to revenue (%): 13.322014490750794
Free cash flow (dilution-adjusted): -2628756.218905472
Buyback yield (%): 0
Receivables turnover: 1.2506295985383438
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -24.066244192680738
FCF margin (%): -26.078415888496238
Revenue growth (%): -13.421884920199409
Rule of 40 score: -39.50030080869565
Financial ratios for ELABS.OL — quarterly report dated 2025-12-31
Total revenue: 4178308.4577114424
Gross profit: 1663184.0796019898
Operating income: -584079.6019900497
Net income: -9466865.671641791
Capital expenditures: 0
Operating cash flow: -330447.7611940298
Depreciation & amortization: 739004.9751243781
Net tangible assets: 11596119.402985074
Owner earnings: -8727860.696517413
Return on net tangible assets (%): -75.26535725624458
Buffett classification: The Gruesome
Stock price: 0.6762948207171315
Shares outstanding: 126336765
Book value: 18705970.14925373
P/B ratio: 4.5675738362635006
Market cap (USD): 85440899.83565737
Debt to equity: 0.06972525865049602
Current ratio: 5.21247732471015
Quick ratio: 5.21247732471015
Interest coverage ratio: -1.2078189300411524
COGS to revenue (%): 60.19479900933512
SG&A to revenue (%): 9.932844351305011
Free cash flow (dilution-adjusted): -1070646.766169154
Buyback yield (%): 0
Receivables turnover: 0.5183941533751419
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.990260004890374
FCF margin (%): -25.623928367308057
Revenue growth (%): -1.3239347642864394
Rule of 40 score: -26.947863131594495